Sweet’s Syndrome as Manifestation of Active Ulcerative Colitis

Bibliographic Details
Main Authors: Mario Bento-Miranda, David N. Perdigoto, Sofia Mendes, Francisco Portela
Format: Article
Language:English
Published: Karger Publishers 2019-08-01
Series:GE: Portuguese Journal of Gastroenterology
Subjects:
Online Access:https://www.karger.com/Article/FullText/501399
id doaj-fee4b83a6805472382aa2451cd476226
record_format Article
spelling doaj-fee4b83a6805472382aa2451cd4762262020-11-25T03:42:57ZengKarger PublishersGE: Portuguese Journal of Gastroenterology2341-45452387-19542019-08-011310.1159/000501399501399Sweet’s Syndrome as Manifestation of Active Ulcerative ColitisMario Bento-MirandaDavid N. PerdigotoSofia MendesFrancisco Portelahttps://www.karger.com/Article/FullText/501399Ulcerative colitisInflammatory bowel diseaseExtraintestinal manifestationsGolimumabInfliximab
collection DOAJ
language English
format Article
sources DOAJ
author Mario Bento-Miranda
David N. Perdigoto
Sofia Mendes
Francisco Portela
spellingShingle Mario Bento-Miranda
David N. Perdigoto
Sofia Mendes
Francisco Portela
Sweet’s Syndrome as Manifestation of Active Ulcerative Colitis
GE: Portuguese Journal of Gastroenterology
Ulcerative colitis
Inflammatory bowel disease
Extraintestinal manifestations
Golimumab
Infliximab
author_facet Mario Bento-Miranda
David N. Perdigoto
Sofia Mendes
Francisco Portela
author_sort Mario Bento-Miranda
title Sweet’s Syndrome as Manifestation of Active Ulcerative Colitis
title_short Sweet’s Syndrome as Manifestation of Active Ulcerative Colitis
title_full Sweet’s Syndrome as Manifestation of Active Ulcerative Colitis
title_fullStr Sweet’s Syndrome as Manifestation of Active Ulcerative Colitis
title_full_unstemmed Sweet’s Syndrome as Manifestation of Active Ulcerative Colitis
title_sort sweet’s syndrome as manifestation of active ulcerative colitis
publisher Karger Publishers
series GE: Portuguese Journal of Gastroenterology
issn 2341-4545
2387-1954
publishDate 2019-08-01
topic Ulcerative colitis
Inflammatory bowel disease
Extraintestinal manifestations
Golimumab
Infliximab
url https://www.karger.com/Article/FullText/501399
work_keys_str_mv AT mariobentomiranda sweetssyndromeasmanifestationofactiveulcerativecolitis
AT davidnperdigoto sweetssyndromeasmanifestationofactiveulcerativecolitis
AT sofiamendes sweetssyndromeasmanifestationofactiveulcerativecolitis
AT franciscoportela sweetssyndromeasmanifestationofactiveulcerativecolitis
_version_ 1724522451023429632